Ímídasókínólínafleiður sem adenósín A3 viðtakabindlar

This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.

Saved in:
Bibliographic Details
Main Authors KINGA BOER, MARIA BALOGH, ENDRE MIKUS, KATALIN URBAN-SZABO, ERZSEBET WALCZ, LASZLO BALAZS, JUDIT VARGANE SZEREDI, PETER ARANYI, KATALIN GERBER, GUZA TYMARI, ZOLTAN KAPUI, LAJOS T. NAGY, SANDOR BATORI
Format Patent
LanguageIcelandic
Published 15.11.2008
Edition7
Online AccessGet full text

Cover

More Information
Summary:This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.
Bibliography:Application Number: IS20050007874